[Correlation of plasma N-acetyl-neuraminic acid level with TIMI risk stratification and clinical outcomes in patients with acute coronary syndrome].

Thrombolysis In Myocardial Infarction risk score acute coronary syndrome plasma N-acetyl-neuraminic acid prognosis

Journal

Nan fang yi ke da xue xue bao = Journal of Southern Medical University
ISSN: 1673-4254
Titre abrégé: Nan Fang Yi Ke Da Xue Xue Bao
Pays: China
ID NLM: 101266132

Informations de publication

Date de publication:
30 Sep 2020
Historique:
entrez: 29 9 2020
pubmed: 30 9 2020
medline: 20 11 2020
Statut: ppublish

Résumé

To explore the correlation of plasma N-acetyl-neuraminic acid level with Thrombolysis In Myocardial Infarction (TIMI) risk score and clinical outcomes of patients with acute coronary syndrome (ACS). We consecutively enrolled 708 consecutive patients (401 male and 307 female, mean age 63.6±10.6 years) undergoing coronary angiography in our hospital between October, 2018 and July, 2019, including 597 patients with ACS and 111 without ACS (control group). The patients with ACS group were divided into high ( Plasma Neu5Ac levels were significantly higher in ACS group than in the control group ( Plasma Neu5Ac level can provide assistance in the diagnosis and risk stratification of ACS and is an independent risk factor for prognosis of ACS patients.

Identifiants

pubmed: 32990230
doi: 10.12122/j.issn.1673-4254.2020.09.05
pmc: PMC7544578
doi:

Substances chimiques

Uric Acid 268B43MJ25

Types de publication

Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

1253-1258

Références

Acta Cardiol Sin. 2018 Jan;34(1):4-12
pubmed: 29375219
Bioinformatics. 2020 Mar 1;36(6):1772-1778
pubmed: 31702773
Emerg Med J. 2020 Jan;37(1):8-13
pubmed: 31767674
Biomed Chromatogr. 2020 Feb;34(2):e4735
pubmed: 31691999
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Nov 1;1099:56-63
pubmed: 30243114
J Atheroscler Thromb. 2019 Sep 1;26(9):747-757
pubmed: 31378756
Circ Cardiovasc Qual Outcomes. 2009 Mar;2(2):108-15
pubmed: 20031822
Circulation. 2018 Mar 27;137(13):1374-1390
pubmed: 29212895
BMC Pharmacol Toxicol. 2020 Jan 3;21(1):1
pubmed: 31900240
Int Heart J. 2019 Nov 30;60(6):1387-1397
pubmed: 31666452
Am J Cardiol. 1983 Feb;51(3):606
pubmed: 6823874
Chem Soc Rev. 2016 Jan 21;45(2):359-76
pubmed: 26750617
Vaccines (Basel). 2019 Nov 01;7(4):
pubmed: 31683930
Cancer Res. 2014 Jun 15;74(12):3199-204
pubmed: 24830719
Anal Bioanal Chem. 2020 Jan;412(3):715-725
pubmed: 31900530
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
Circulation. 2000 Oct 24;102(17):2031-7
pubmed: 11044416
Clin Chem. 1971 Dec;17(12):1154-9
pubmed: 5118153
JAMA. 2000 Aug 16;284(7):835-42
pubmed: 10938172
Circulation. 2001 Jun 19;103(24):3019-41
pubmed: 11413094
J Am Coll Cardiol. 2016 Sep 20;68(12):1281-93
pubmed: 27634119
Diab Vasc Dis Res. 2020 Jan-Feb;17(1):1479164119892137
pubmed: 31841030
Nutr Metab Cardiovasc Dis. 2020 Mar 9;30(3):467-473
pubmed: 31831367
Drug Des Devel Ther. 2018 Oct 10;12:3431-3437
pubmed: 30349196
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Oct 24;47(10):766-783
pubmed: 31648459

Auteurs

Miaonan Li (M)

Department of Cardiovascular Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Cheeloo College of Medicine, Shangdong University, Bengbu 233004, China.

Shaohuan Qian (S)

Department of Cardiovascular Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.

Zhuoya Yao (Z)

Department of Cardiovascular Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.

Shengping Min (S)

Anhui Clinical and Preclinical Key Laboratory of Respriatory Disease, Bengbu 233004, China.

Xiaojun Shi (X)

Department of Cardiovascular Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.

Pinfang Kang (P)

Department of Cardiovascular Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.

Ningru Zhang (N)

Department of Cardiovascular Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.

Xiaojing Wang (X)

Anhui Clinical and Preclinical Key Laboratory of Respriatory Disease, Bengbu 233004, China.

Dasheng Gao (D)

Department of Cardiovascular Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.

Qin Gao (Q)

Anhui Provincial Key Laboratory of Computational Medicine and Intelligent Health, Bengbu 233004, China.

Heng Zhang (H)

Department of Cardiovascular Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.

Hongju Wang (H)

Department of Cardiovascular Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH